Advertisement
Advertisement
At close: 04:00PM EST
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 84.44 |
| Open | 84.24 |
| Bid | 83.29 x 800 |
| Ask | 85.79 x 900 |
| Day's Range | 83.45 - 85.31 |
| 52 Week Range | 59.78 - 85.31 |
| Volume | |
| Avg. Volume | 1,617,203 |
| Market Cap | 20.878B |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | 16.22 |
| EPS (TTM) | 5.22 |
| Earnings Date | Apr 25, 2023 - May 01, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 86.38 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-16% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for HOLX
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Hologic, Inc.Analyst Report: Hologic, Inc.Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.RatingFair ValueEconomic Moat2 days agoMorningstar
- Zacks
Zimmer Biomet (ZBH) Q4 Earnings Beat Estimates, Margins Up
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions record year-over-year sales growth at CER.
- Zacks
CONMED (CNMD) Down on Q4 Earnings Miss, New System Hurts Sales
CONMED's (CNMD) adjusted fourth-quarter sales and earnings reflect disruption due to implementation of a new warehouse management system.
- Zacks
Cardinal Health (CAH) Q2 Earnings Top, EPS Outlook Raised
Cardinal Health's (CAH) fiscal second-quarter results benefit from the solid performance of the Pharmaceutical segment.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
